Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

By LabMedica International staff writers
Posted on 12 May 2026

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. More...

For bipolar disorder, average time to diagnosis can exceed nine years, and assessments for attention-deficit/hyperactivity disorder (ADHD) and anorexia in young people often face lengthy waits. Objective, noninvasive biomarkers remain scarce in routine mental health assessment. Researchers now report urinary metabolite signatures that may enable earlier identification of these conditions.

At the University of Cambridge, investigators from the Department of Chemical Engineering and Biotechnology and the Yusuf Hamied Department of Chemistry identified 67 urinary metabolite markers associated with multiple psychiatric conditions. Twenty-one of these markers were unique to a single disorder. The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier clinical decision-making.

The team applied a Mendelian randomization framework, a genetic method that mimics a genomic clinical trial, to test causal links between psychiatric diagnoses and urine chemistry. By leveraging existing datasets, the approach circumvents the time and cost of conventional laboratory biomarker screening. The analysis highlighted distinct metabolite–disorder relationships that could be translated into targeted diagnostic panels pending clinical validation.

Examples cited include altered levels of vitamin B6 (pyridoxal) in anorexia, N,N-dimethylglycine in ADHD, and condition-specific shifts in creatine and tyrosine linked to bipolar disorder and schizophrenia, respectively. The authors emphasize that the candidate markers require testing in real-world clinical trials before integration into care pathways. The study was in BMC Psychiatry on May 7.

The work builds on prior outputs from the Cambridge groups, including earlier findings published in Scientific Reports last year, as well as department efforts exploring urine-based detection strategies in other diseases. Collectively, the cross-departmental program underscores the value of integrating chemistry, biotechnology, and data science to refine objective measures for psychiatric assessment.

“A urine test is quick, non-invasive and routine procedure in health care. If these findings hold up in clinical trials, we could offer GPs and mental health teams a practical tool to support earlier diagnosis—and reduce pressure on overstretched NHS services,” said Sabine Bahn, corresponding author and head of the Cambridge Center for Neuropsychiatric Research.

CEB University of Cambridge
Yusuf Hamied Department of Chemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.